论文信息 - Efficacy and tolerability of once‐weekly selinexor, bortezomib, and dexamethasone in comparison with standard twice‐weekly bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the BOSTON study - 字舞流文

Efficacy and tolerability of once‐weekly selinexor, bortezomib, and dexamethasone in comparison with standard twice‐weekly bortezomib and dexamethasone in previously treated multiple myeloma with renal impairment: Subgroup analysis from the BOSTON study

M. Dimopoulos | P. Richardson | R. Benjamin | R. Hájek | P. Moreau | X. Leleu | M. Gavriatopoulou | H. Auner | M. Mateos | S. Shacham | M. Garg | Y. Chai | C. Venner | S. Delimpasi | H. Pylypenko | V. Doronin | T. Dolai | D. Sinha | H. Quach | Melina Arazy | M. Kauffman | S. Grosicki | Yair Levy | J. Shah | Y. Levy